Generic name: METIPRANOLOL 3mg in 1mL
Dosage form: ophthalmic solution
Medically reviewed on January 15, 2018.
The recommended dose is one drop of OptiPranolol Ophthalmic Solution in the affected eye(s) twice a day.
If the patient’s IOP is not at a satisfactory level on this regimen, use of more frequent administration or a larger dose of OptiPranolol Ophthalmic Solution is not known to be of benefit. Concomitant therapy to lower intraocular pressure can be instituted.
In clinical trials, OptiPranolol® Ophthalmic Solution was safely used during concomitant therapy with pilocarpine, epinephrine or acetazolamide.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about OptiPranolol (metipranolol ophthalmic)
- OptiPranolol Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 0 Reviews
- Generic Availability
- Drug class: ophthalmic glaucoma agents